E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial.
Christian T. Ruff,Robert P. Giugliano,Eugene Braunwald,Sabina A. Murphy,Karen Brown,Petr Jarolim,Michele Mercuri,Elliott M. Antman,David A. Morrow +8 more
TL;DR: A prototype multimarker risk score was developed to determine the probability of stroke, systemic embolic events, or death by assigning tiered points for higher concentrations of the biomarkers to improve prognostic accuracy in patients with atrial fibrillation.
Journal ArticleDOI
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis
Roberto R. Giraldez,Jose C. Nicolau,Ramón Corbalán,Enrique P. Gurfinkel,Ursulo Juarez,Jose Lopez-Sendon,Alexander Parkhomenko,Peter Molhoek,Satishkumar Mohanavelu,David A. Morrow,Elliott M. Antman +10 more
TL;DR: Death, nonfatal MI, or major bleeding was significantly reduced with enoxaparin in the fibrin-specific cohort (OR(adj) 0.82; 95% CI 0.74-0.91; P < 0.001) and the benefits of an en oxaparin strategy over UFH were observed in both SK and fibrIn-specific-treated STEMI patients.
Journal ArticleDOI
2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice.
TL;DR: The American College of Cardiology and American Heart Association have issued a "focused update" of their 2004 guidelines for the management of ST-segment elevation myocardial infarction, and new recommendations on treatment decisions that may be made in the emergency department are presented.
Journal ArticleDOI
Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis.
TL;DR: The likelihood of developing VF in the early hours after thrombolysis for acute myocardial infarction is similar in patients receiving throm bolytics or placebo, however, throughout the hospital course, the risk ofVF is greater in patients Receiving placebo, whereas therisk ofVT is higher in patients received thromBOlysis.
Journal ArticleDOI
Advantages and limitations of metaanalytic regressions of clinical trials data
TL;DR: In this article, a meta-analysis of data from 20 years of randomized trials of lidocaine prophylaxis in preventing primary ventricular fibrillation (VF) in myocardial infarction used separate data for control and active-treatment groups.